BDBM502349 N-(4-{7-[1- (2-methoxy- ethyl)-1H- benzoimid- azole-2-yl]-1- methyl- [1,2,4]tri- azolo[4,3- a]quinoxaline- 4-ylamino}- butyl)-3- methyl-::US11028090, Example 241

SMILES COCCn1c(nc2ccccc12)-c1ccc2c(c1)nc(NCCCCNC(=O)CC(C)C)c1nnc(C)n21

InChI Key InChIKey=NHEHTOMPORYDMF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 502349   

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandPNGBDBM502349(N-(4-{7-[1- (2-methoxy- ethyl)-1H- benzoimid- azol...)
Affinity DataIC50: 7nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
Go to US Patent